Polycystic ovarian syndrome (commonly referred to as PCOS) is an ovulation disorder that impacts roughly 1 in 10 reproductive age women. The disorder is characterized by infrequent periods, elevated androgens and a multi cystic appearance of the ovaries on ultrasound.
As women approach menopause, they often encounter a range of physical and emotional symptoms that can negatively impact their quality of life. Hormone Replacement Therapy (HRT), or Menopausal Hormone Therapy (MHT), refers to medical management of these symptoms using supplemental estrogen plus or minus progesterone. In this blog, we’ll delve into the nuanced landscape of MHT, exploring advantages, associated risks, and the populations of women who might benefit from it.
